Study guide
13.3 Infectious Disease Principles & Systemic Pathogens
USMLE Step 2 CK Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Human Development & Well-Patient Care
1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening
2 Chapter 2: Immune System & Immunologic Disorders
2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles
3 Chapter 3: Blood & Lymphoreticular System
3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders
4 Chapter 4: Behavioral Health & Psychiatric Disorders
4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology
5 Chapter 5: Nervous System & Special Senses
5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies
6 Chapter 6: Musculoskeletal System & Dermatology
6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders
7 Chapter 7: Cardiovascular System
7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease
8 Chapter 8: Respiratory System
8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases
9 Chapter 9: Gastrointestinal System
9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis
10 Chapter 10: Renal, Urinary & Reproductive Systems
10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease
11 Chapter 11: Pregnancy, Childbirth & Puerperium
11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management
12 Chapter 12: Endocrine System
12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology
13 Chapter 13: Multisystem Processes & Critical Care
13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens
14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation
14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine
15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice
15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions
13.3 Infectious Disease Principles & Systemic Pathogens
Key Takeaways Explain This Topic AI
Fever of Unknown Origin (FUO) is defined as body temperature > 38.3°C (101.0°F) on multiple occasions lasting > 3 weeks, with no diagnosis established after 1 week of comprehensive inpatient or outpatient evaluation.
Neutropenic fever is defined as a single oral temperature >= 38.3°C (101.0°F) or >= 38.0°C (100.4°F) sustained for > 1 hour in a patient with an absolute neutrophil count (ANC) < 500/mm³; it requires immediate empiric monotherapy with an antipseudomonal beta-lactam (e.g., cefepime, piperacillin-tazobactam, meropenem).
Rocky Mountain Spotted Fever (Rickettsia rickettsii) presents with fever, headache, and a maculopapular rash starting on wrists and ankles that spreads centripetally and becomes petechial; oral doxycycline is the first-line treatment for all ages, including young children.
Babesiosis (Babesia microti) causes fever, hemolytic anemia, and jaundice following Ixodes tick exposure in the Northeastern US; peripheral blood smear displays intraerythrocytic tetrads ('Maltese cross'), treated with atovaquone plus azithromycin.
Central line-associated bloodstream infections (CLABSI) are most commonly caused by Staphylococcus epidermidis (coagulase-negative staphylococci), Staphylococcus aureus, and Candida species; prevention requires full barrier precautions and chlorhexidine skin antisepsis during insertion.
Last updated: July 2026
13.3 Infectious Disease Principles & Systemic Pathogens
Systemic infectious diseases present diagnostic challenges due to overlapping systemic manifestations. USMLE Step 2 CK emphasizes structured clinical evaluations for Fever of Unknown Origin (FUO), emergency management of neutropenic fever, differential diagnosis of vector-borne zoonoses, and prevention of healthcare-associated systemic infections.
- Fever of Unknown Origin (FUO)
- Diagnostic Criteria
Classic Fever of Unknown Origin (FUO) is defined by three strict clinical criteria:
Body temperature > 38.3 ∘ C > 38.3^\circ\text{C} > 38. 3 ∘ C ( 101.0 ∘ F 101.0^\circ\text{F} 101. 0 ∘ F ) recorded on multiple occasions,
Fever duration > 3 weeks > 3 \text{ weeks} > 3 weeks , and
No definitive diagnosis established after 1 week 1 \text{ week} 1 week of intensive outpatient or inpatient investigation (or 3 outpatient visits / 3 days of inpatient testing).
Etiologic Spectrum
FUO cases fall into four major diagnostic categories:
Category Frequency Common Specific Etiologies Key Diagnostic Clues
Infections 30 – 40 % 30\text{--}40\% 30 – 40% Endocarditis, occult abscesses (intra-abdominal, pelvic), TB, EBV/CMV, HIV, osteomyelitis New murmur, night sweats, localized pain, travel history
Malignancies 20 – 30 % 20\text{--}30\% 20 – 30% Renal cell carcinoma, Lymphomas (Hodgkin/Non-Hodgkin), Leukemias, Myelodysplasia Weight loss, B symptoms, LDH elevation, erythrocytosis
Connective Tissue / Autoimmune 15 – 20 % 15\text{--}20\% 15 – 20% Giant cell arteritis, Adult-onset Still disease, SLE, Polyarteritis nodosa ESR/CRP > 100 > 100 > 100 , joint pain, salmon-colored rash, headache
Miscellaneous / Drug Fever 10 – 15 % 10\text{--}15\% 10 – 15% Drug-induced fever (beta-lactams, anticonvulsants), Subacute thyroiditis, PE Temporal relation to medication initiation, relative bradycardia
Febrile Neutropenia Protocol
Febrile neutropenia is a medical emergency requiring immediate empiric broad-spectrum intravenous antimicrobial therapy due to high risk of overwhelming bacterial sepsis.
Definitions
Fever: A single oral temperature ≥ 38.3 ∘ C \ge 38.3^\circ\text{C} ≥ 38. 3 ∘ C ( 101.0 ∘ F 101.0^\circ\text{F} 101. 0 ∘ F ) OR a sustained temperature ≥ 38.0 ∘ C \ge 38.0^\circ\text{C} ≥ 38. 0 ∘ C ( 100.4 ∘ F 100.4^\circ\text{F} 100. 4 ∘ F ) for > 1 hour > 1 \text{ hour} > 1 hour .
Neutropenia: Absolute Neutrophil Count (ANC) < 500 / mm 3 < 500/\text{mm}^3 < 500/ mm 3 , or an ANC expected to fall < 500 / mm 3 < 500/\text{mm}^3 < 500/ mm 3 within 48 hours. ANC calculation: ANC = Total WBC count × ( % Neutrophils + % Bands 100 ) \text{ANC calculation: } \text{ANC} = \text{Total WBC count} \times \left(\frac{\% \text{Neutrophils} + \% \text{Bands}}{100}\right) ANC calculation: ANC = Total WBC count × ( 100 % Neutrophils + % Bands )
Empiric Antibiotic Selection
Because neutropenic patients lack functional white blood cells to produce classic signs of localized inflammation (e.g., purulence), Pseudomonas aeruginosa and enteric Gram-negative bacilli can cause rapid mortality.
First-line Empiric Monotherapy: Immediate administration of an antipseudomonal β \beta β -lactam:
- Cefepime ( 2 g 2 \text{ g} 2 g IV q8h), OR
- Piperacillin-tazobactam ( 4.5 g 4.5 \text{ g} 4.5 g IV q6h), OR
Meropenem ( 1 g 1 \text{ g} 1 g IV q8h).
Indications to Add Vancomycin: Vancomycin is NOT routinely included in initial empiric therapy unless specific indications exist: hemodynamic instability/septic shock, catheter-related infection, skin/soft tissue infection, known MRSA colonization, or pneumonia. FEBRILE NEUTROPENIA EMERGENCY ALGORITHM
- Single Temp >= 38.3°C (101°F) + ANC < 500/mm³
- |
- v
- Immediate Blood Cultures x 2 (Peripheral + Central Line)
- + Urinalysis, CXR, Physical Exam (DO NOT perform digital rectal exam!)
- |
- v
- Administer Empiric IV Antipseudomonal Monotherapy < 60 Min
- (Cefepime 2g IV OR Piperacillin-tazobactam 4.5g IV)
- |
- +-----------------------+-----------------------+
- | |
- No MRSA / Shock Signs Hemodynamic Instability /
- | Catheter Infection / MRSA Risk
- v v
- Continue Monotherapy Add IV Vancomycin to
- Re-evaluate at 48-72 hours Antipseudomonal Beta-Lactam
- Vector-Borne and Systemic Zoonotic Pathogens
Vector-borne infections present with characteristic cutaneous findings, geographic exposures, and peripheral blood features:
Pathogen / Disease Vector / Reservoir Geographic Distribution Clinical Features & Labs Treatment
Lyme Disease ( Borrelia burgdorferi ) Ixodes tick / White-footed mouse Northeast & Upper Midwest US Erythema migrans (bullseye rash), AV block, facial nerve palsy, arthritis Oral Doxycycline ( 100 mg 100 \text{ mg} 100 mg BID); IV Ceftriaxone for carditis/CNS
Rocky Mountain Spotted Fever ( Rickettsia rickettsii ) Dermacentor tick / Dogs, rodents South-Central & Southeastern US Fever, severe headache, petechial rash starting on wrists/ankles spreading to trunk Oral/IV Doxycycline (first-line for ALL ages, including children)
Babesiosis ( Babesia microti ) Ixodes tick / Rodents Northeast US (Nantucket, Martha's Vineyard) Hemolytic anemia, jaundice, splenomegaly; Maltese cross intraerythrocytic tetrads Atovaquone + Azithromycin
Anaplasmosis / Ehrlichiosis Ixodes / Amblyomma ticks Northeast (Anaplasma) / South-Central (Ehrlichia) Fever, leukopenia, thrombocytopenia, elevated LFTs; Morulae in granulocytes/monocytes Oral/IV Doxycycline
Malaria ( Plasmodium falciparum ) Anopheles mosquito Sub-Saharan Africa, Tropics Cyclical fevers, hemolytic anemia, splenomegaly; blood smear shows ring forms Artemether-lumefantrine or Atovaquone-proguanil
Leptospirosis ( Leptospira interrogans ) Water contaminated with animal urine (rats) Tropical regions, kayakers Conjunctival suffusion (red eyes without exudate), jaundice, renal failure ( Weil disease ) Oral Doxycycline or IV Penicillin G
- Healthcare-Associated Systemic Infections
- Central Line-Associated Bloodstream Infections (CLABSI)
CLABSI is defined as a primary bloodstream infection occurring in a patient with a central venous catheter in place for > 48 hours > 48 \text{ hours} > 48 hours prior to infection onset, which is not secondary to infection at another site.
Most Common Pathogens:
Coagulase-negative Staphylococci ( Staphylococcus epidermidis ) — most common overall (biofilm formation).
Staphylococcus aureus (both MSSA and MRSA).
Candida species (especially in parenteral nutrition, prolonged broad-spectrum antibiotics).
Enteric Gram-negative bacilli ( E. coli , Klebsiella , Pseudomonas ).
Prevention Bundle: Strict hand hygiene, maximal sterile barrier precautions during insertion, chlorhexidine skin antisepsis , avoidance of femoral vein insertion site, and daily review of line necessity with prompt removal of unneeded catheters.